Hyperpigmentation Treatment Market Size, Share, Growth, And Industry Analysis By Type (Pharmacological Therapy, Laser Treatment, Chemical Peels and Bleach, Microdermabrasion, and Skin Grafting or Plastic Surgery) By Application (Skin Clinics, Drug and Cosmetic Stores, and Hypermarkets and Supermarkets), Regional Insights and Forecast From 2025 To 2034

•   
•   
  

  Request a Free sample to learn more about this report

    

HYPERPIGMENTATION TREATMENT MARKET OVERVIEW

The global Hyperpigmentation Treatment Market size stood at USD 0.65 billion in 2025, growing further to USD 1.76 billion by 2034 at an estimated CAGR of 11.7% from 2025 to 2034.

The United States Hyperpigmentation Treatment Market size is projected at USD 0.19625 billion in 2025, the Europe Hyperpigmentation Treatment Market size is projected at USD 0.1708 billion in 2025, and the China Hyperpigmentation Treatment Market size is projected at USD 0.20347 billion in 2025.

Pigmentation is the term used to describe regions of the skin that are darker in color than the surrounding skin, frequently giving the area a patchy or uneven look. Freckles and sunspots, melasma or chloasma, seborrheic keratosis, and birthmarks are all examples of pigmentation. Use of ineffective skin care products, ongoing sun exposure, and heat injury can all exacerbate it. Melanocytes in the deeper layers of the skin create melanin, a pigment that darkens the skin, which leads to hyperpigmentation. Disorders of hyperpigmentation are treatable with cosmeceuticals, laser therapy, and chemical peels. The global market for the treatment of hyperpigmentation diseases is also being driven by the rise in melasma prevalence and increased knowledge of hyperpigmentation treatments.

The market for the treatment of hyperpigmentation diseases is being stimulated by the demand for post-inflammatory hyperpigmentation (PIH) treatments. the proportion of people with darker skin colors. There is still an unmet demand in the global market for the treatment of hyperpigmentation disorders, despite the fact that there is a vast body of research on the pathophysiology of PIH. To close this gap, various formulations including hydroquinone, tretinoin, and dexamethasone are being investigated.

KEY FINDINGS

COVID-19 IMPACT

Pandemic Negatively Impacted Market Trends

The market for treating pigmentation disorders has been disrupted by the COVID-19 pandemic. In order to gauge the pandemic's effects, Hamilton Fraser Cosmetic Insurance surveyed 1,360 UK cosmetic specialists in March 2020. According to the survey, the pandemic had an impact on 99.78% of them and their profession. Patients must be triaged during the COVID-19 pandemic to prevent needless hospitalization due to minor injuries and other illnesses. Additionally, it is wise to refrain from bringing patients in for routine check-ups and minor concerns. Although non-urgent clinical and surgical treatments must be delayed until the situation gets better, the hospital must nonetheless ensure the patients receive high-quality care. The market under investigation has been greatly impacted because the majority of cosmetic operations can be considered non-essential.

LATEST TRENDS

Over the Forecast Period, the Topical Treatment Segment Is Anticipated to Maintain a Sizeable Market Share

Due to increased clinical results in patients with pigmentation disorders, the topical treatment sector currently rules the global market. The most often given topical medications worldwide are azelaic acid, hydroquinone, L-ascorbic acid, etc. To treat various pigmentation problems, topical treatment comprises using creams, lotions, ointments, and serum topically. A range of active ingredients are used to create these products. According to market trends for treating hyperpigmentation diseases worldwide, melasma prevalence is predicted to climb in the coming years, along with the number of available treatments.

• According to our research a 28% rise in demand for natural ingredient-based pigmentation treatments globally between 2020 and 2024.

• According to our research, non-invasive light-based treatments have seen a 33% increase in adoption in clinical settings since 2022.

•   
•   
  

  Request a Free sample to learn more about this report

    

HYPERPIGMENTATION TREATMENT MARKET SEGMENTATION

• By Type

According to type, the market can be segmented into Pharmacological Therapy, Laser Treatment, Chemical Peels and Bleach, Microdermabrasion, Skin Grafting or Plastic Surgery. Pharmacological Therapy will be the leading segment during the forecast period.

• By Application

Based on application, the market can be divided into Skin Clinics, Drug and Cosmetic Stores, Hypermarkets and Supermarkets. Skin Clinics are anticipated to have the dominant market share.

DRIVING FACTORS

Market Growth Is Being Driven By A Rise In Prevalence of Melasma

Based on disease indication, the melasma segment held the greatest market share for treatments for hyperpigmentation disorders globally in 2021. Melasma is a symmetrical hyperpigmentation disorder that is primarily acquired and affects the face. Women and those with darker complexion tones are more likely to experience it. Melasma is a common skin disease, particularly in pregnant women. 15% to 50% of expectant mothers have melasma. Melasma commonly manifests during a woman's reproductive years and seldom during adolescence. It can affect 1.5% to 33% of persons. Usually, it starts between the ages of 20 and 40. High demand for dermatological care has resulted from an increase in melasma prevalence and a preference for cosmeceutical treatments. In the United States, melasma affected more than 5 million people in 2020, and it can impact up to 30% of Asian women of reproductive age. It is hard to treat and recurs frequently. Recent years have seen considerable advancements in the pathophysiology, clinical staging & classification, and clinical management of melasma.

Offering Laser Therapy & Phototherapy to Support Dermatology & Esthetic Clinics

The segment of aesthetic clinics and dermatology facilities is anticipated to hold the largest market share for the treatment of hyperpigmentation disorders globally during the forecast period. In the near future, the segment is anticipated to be driven by an increase in the number of dermatological and aesthetic clinics. To address the rising demand for treatments for hyperpigmentation disorders, producers and dealers of cosmeceuticals for hyperpigmentation are enhancing their supply chains. A number of firms are being encouraged by other big players and retailers to use an omnichannel supply strategy to get their products to customers.

• According to our research indicates that over 50% of patients seek hyperpigmentation treatment due to cosmetic concerns linked to social media influence.

• According to our research, 18 million prescriptions for skin lightening agents were issued in the U.S. in 2023, reflecting growing market need.

RESTRAINING FACTORS

High Cost Of Cosmetic Procedure Limiting The Market Growth

During the forecast period, it is projected that the high cost of treatments for pigmentation disorders will prevent more people from using them. Therefore, the market may experience slower growth in low- and middle-income regions.

• According to our research reports that up to 20% of users experience side effects from traditional hydroquinone-based treatments, restraining market growth.

• According to our research, lack of regulatory harmonization across regions delays product approvals by an average of 12 months.

•   
•   
  Request a Free sample to learn more about this report

    

HYPERPIGMENTATION TREATMENT MARKET REGIONAL INSIGHTS

North America to Dominate the Market Forecast during forecast period

Due to the rising prevalence of pigmentation disorders, the region's established healthcare infrastructure, and the presence of major market players offering post-inflammatory hyperpigmentation patients effective treatment options, North America dominates the global market for treating pigmentation disorders. For instance, according to a StatPearls article named "Albinism" that was published in August 2021, the American area has the highest prevalence of albinism (1:36,000). Additionally, according to the same source, the prevalence rate for African Americans is 1:10,000. The rising frequency of albinism in the nation is therefore anticipated to increase demand for treatments for pigmentation disorders, which will further drive market expansion over the forecast period.

KEY INDUSTRY PLAYERS

Key Players Focus on Partnerships to Gain a Competitive Advantage

Prominent market players are making collaborative efforts by partnering with other companies to stay ahead of the competition. Many companies are also investing in new product launches to expand their product portfolio. Mergers and acquisitions are also among the key strategies used by players to expand their product portfolios.

• Alvogen, Inc.: Alvogen launched 7 new hyperpigmentation treatment products in 2023, expanding their portfolio by 25%.

• Allergan, Inc.: Allergan holds over 15 active clinical trials in pigmentary disorder treatments as of 2025.

List of Top Hyperpigmentation Treatment Companies

• Alvogen, Inc.
• Allergan, Inc.
• La Roche-Posay
• Episciences, Inc.
• Biocosmetic Research Labs
• L?oréal Paris
• Vivier Pharma, Inc.
• SkinCeuticals International
• Obagi Medical Products Inc.
• Pierre Fabre Dermo Cosmetique
• Bayer AG

REPORT COVERAGE

This research profiles a report with extensive studies that take into description the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by inspecting the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, and restraints. This analysis is subject to alteration if the key players and probable analysis of market dynamics change.